Doctor profile · Federal record
Dr. EDWARD ESPARZA, MD
Dermatology Physician (CMS: DERMATOLOGY) · BELLEVUE, WA
- NPI 1427258797
- Accepts Medicare
- 19 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
11695 NE 4TH ST
BELLEVUE, WA 980045268
(425) 637-1855 - Additional location
-
1100 9th Ave, X9-DERM
Seattle, WA 981012756
(206) 341-0895
fax (206) 341-0155 - Mailing address
-
1100 9TH AVE, MS:M4-PFS
SEATTLE, WA 981012756
Credentials & registration
- NPI registered
- July 2007 — 19 yrs on file
- Profile last updated
- July 23, 2020
- Year of graduation
- 2007 — 19 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Washington #MD60217226
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1427258797. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
3,209
Distinct HCPCS
10
Medicare allowed
$242,809
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,133 | 268 | $8 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 518 | 389 | $141 | |
17000 |
Destruction of precancer skin growth, 1 growth | 450 | 358 | $67 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 361 | 312 | $101 | |
11102 |
Biopsy of related skin growth, first growth | 262 | 233 | $117 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 138 | 138 | $182 | |
11103 |
Biopsy of related skin growth, each additional growth | 115 | 71 | $58 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 110 | 110 | $125 | |
17110 |
Destruction of skin growth, 1-14 growths | 37 | 35 | $135 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 31 | 26 | $198 |
In context: peer comparison
Among 5 peers in this city , average services per provider: 424. This provider delivers 7.6× the peer median.Open Payments
Industry payments received
All-time total
$239
Transactions
3
Manufacturers
3
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Dermavant Sciences, Inc. | 1 | $98.61 | |
| PFIZER INC. | 1 | $96.37 | |
| Incyte Corporation | 1 | $44.09 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
933
Patients
504
Total drug cost
$30,647
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 122 | 77 | $2,820 |
| Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) | Brand | 114 | 47 | $5,561 |
| Ketoconazole | Generic | 85 | 42 | $1,615 |
| Clobetasol Propionate | Generic | 84 | 38 | $6,036 |
| Mometasone Furoate | Generic | 78 | 57 | $1,160 |
| Doxycycline Hyclate | Generic | 69 | 31 | $2,687 |
| Hydrocortisone | Generic | 63 | 38 | $428 |
| Metronidazole | Generic | 55 | 33 | $3,638 |
| Finasteride | Generic | 50 | 15 | $489 |
| Mupirocin | Generic | 48 | 42 | $451 |